Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 3—March 2026

Online Report

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group

Alessandro C. PasqualottoComments to Author , David W. Denning, Thuy Le, Nelesh P. Govender, Ferry Hagen, Rosely M. Zancope-Oliveira, Diego H. Caceres, Ugo Francoise, Allan Guimaraes, Lisandra S. Damasceno, Diego R. Falci, Beatriz L. Gomez, Ilan Schwartz, Jose E. Vidal, Luis E. Galan, Melissa O. Xavier, Mathieu Nacher, Guillermo G. Effron, Gordon Brown, Nicolas Barros, Cassia M. Godoy, Taiguara Fraga, Renata B.A. Soares, Cecilia B. Severo, Alexandre V. Schwarzbold, Indira Berrio, Marineide G. de Melo, Nicole Reis, Bernardo G. Tenorio, Terezinha M.J. Leitao, Claudilson J. de C. Bastos, Monica B. Bay, Marcus V.G. de Lacerda, Luana C.G. Bazana, Daiane F. Dalla Lana, Tarsila Vieceli, Cezar V.W. Riche, Eduardo Arathoon, Cristina Canteros, David Boulware, Ana Alastruey-Izquierdo, Rita Oladele, Marcus de M. Teixeira, Arnaldo L. Colombo, Freddy M. Perez, Tom Chiller, Nathan C. Bahr, Juan L.R. Tudela, and Antoine Adenis
Author affiliation: Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil (A.C. Pasqualotto, C.B. Severo, N. Reis, L.C.G. Bazana, D.F. Dalla Lana, T. Vieceli, C.V.W. Riche, F.M. Perez); Santa Casa de Porto Alegre, Porto Alegre (A.C. Pasqualotto, C.V.W. Riche); University of Manchester, Manchester, UK (D.W. Denning); Duke University, Durham, North Carolina, USA (T. Le, I. Schwartz); University of Witwatersbrand, Johannesburg, South Africa (N.P. Govender); Westerdijk Fungal Biodiversity Institute, Utrecht, the Netherlands (F. Hagen); Fundação Oswaldo Cruz, Rio de Janeiro, Brazil (R.M. Zancope-Oliveira); IMMY, Norman, Oklahoma, USA (D.H. Caceres, T. Chiller); Université de Guyane, Cayenne, French Guiana (U. Francoise, M. Nacher, A. Adenis); Fluminense Federal University, Niteroi, Brazil (A. Guimaraes); Federal University of Ceara, Fortaleza, Brazil (L.S. Damasceno, T.M.J. Leitao); Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (D.R. Falci); Hospital de Clínicas de Porto Alegre, Porto Alegre (D.R. Falci); Universidad del Rosario, Bogotá, Colombia (B.L. Gomez); Emilio Ribas Institute, São Paulo, Brazil (J.E. Vidal); Hospital Geral de Roraima, Boa Vista, Brazil (L.E. Galan); Federal University of Rio Grande, Rio Grande, Brazil (M.O. Xavier); Universidad Nacional del Litoral, Santa Fe, Argentina (G.G. Effron); University of Exeter, Exeter, UK (G. Brown); MiraVista Diagnostics, Indianapolis, Indiana, USA (N. Barros); Indiana University, Indianapolis (N. Barros); Pontifical Catholic University of Goias, Goiania, Brazil (C.M. Godoy, T. Fraga, R.B.A. Soares); Federal University of Santa Maria, Santa Maria, Brazil (A.V. Schwarzbold); Hospital General de Medellín, Medellín, Colombia (I. Berrio); Hospital Nossa Senhora da Conceição, Porto Alegre (M.G. de Melo); Hospital Vila Nova, Porto Alegre (N. Reis); Brasilia University, Brasília, Brazil (B.G. Tenorio, M. de M. Teixeira); Bahia State University, Salvador, Brazil (C.J. de C. Bastos); Federal University of Rio Grande do Norte, Natal, Brazil (M.B. Bay); Tropical Medicina Foundation, Manaus, Brazil (M.V.G. de Lacerda); Hospital General San Juan de Dios, Guatemala City, Guatemala (E. Arathoon); National Laboratory of Clinical Mycology, Buenos Aires, Argentina (C. Canteros); University of Minnesota, Minneapolis, Minnesota, USA (A.C. Pasqualotto, D. Boulware, N.C. Bahr); Spanish National Centre for Microbiology, Madrid, Spain (A. Alastruey-Izquierdo); Global Action for Fungal Infections, Geneva, Switzerland (A. Alastruey-Izquierdo, T. Chiller, J.L.R. Tudela); University of Lagos, Lagos, Nigeria (R. Oladele); Pan American Health Organization, Washington, DC, USA (F.M. Perez)

Main Article

Figure

Proposed 90–90–90 global targets for symptomatic histoplasmosis control in all at-risk populations by 2030 from the International Society for Human and Animal Mycology 2025 Histoplasmosis Working Group.

Figure. Proposed 90–90–90 global targets for symptomatic histoplasmosis control in all at-risk populations by 2030 from the International Society for Human and Animal Mycology 2025 Histoplasmosis Working Group.

Main Article

Page created: February 08, 2026
Page updated: March 20, 2026
Page reviewed: March 20, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external